Life Saving Diagnostics!
Detecting biomarkers and bacteria in less than 30 mintues.
Our Chemistry. Our Device. Anywhere You Need It.
A custom-built portable reader designed to deliver our proven chemistry in the field.
About Us
CEXAL LTD is a Scottish-based biotech company revolutionizing microbial testing through the use of novel class of DNA biosensors.
Since 2021, we have invested in the development of rapid, easy-to-use, point-of-need diagnostics (30 minutes or less) that significantly surpass current gold-standard methods for microbial detection.
This technology has demonstrated validated performance for bacterial detection across complex sample matrices, including environmental waters (DEFRA, UK), urine (NHS, UK), and, more recently, rocket fuel (UK Space Agency).
Compared to other rapid assays, our proprietary patent-pending technology:
- is built using only two—just two—functional DNA probes
- Can be used directly on clinical or environmental samples
- Is compatible with standard readers and workflows
- Can be delivered as a lateral flow cartridge (LFA) for rapid deployment
- Provides definitive results comparable to laboratory methods
Products
One core chemistry. Multiple capabilities. From bacterial genotyping and phenotyping to small-molecule analysis, our proprietary technology powers a versatile suite of molecular assays.
FluoCDx Platform
Detect bacteria in 5 minutes and provides antibiotic susceptibility testing in 30. All in a single step.
Team
Our mission is to save lives by creating simple, fast, and affordable molecular diagnostics for those who need them most.
Dr Praveenkumar Kaveri
Chief Scientific OfficerSkilled Healthcare Diagnostic Specialist with 13 years of experience in Assay Development
Matteo Cese
Chief Executive OfficerBioeconomist with nearly a decade of experience working with deep-tech high-growth startups